Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (221-230 of 858) with videos related to

Pageof 86
Sort By:
American Heart Journal|May 26, 2009
Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF)Daniel E Forman, Christopher P Cannon, Adrian F Hernandez, et al.
Journal of the American College of Cardiology|October 16, 2010
Prior aspirin use and outcomes in acute coronary syndromesJonathan D Rich, Christopher P Cannon, Sabina A Murphy, et al.
Critical Pathways in Cardiology|August 31, 2010
Performance achievement award program for Get With The Guidelines--Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarctionKim K Birtcher, Wenqin Pan, Kenneth A Labresh, et al.
Journal of the American College of Cardiology|May 17, 2005
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trialPaul M Ridker, David A Morrow, Lynda M Rose, et al.
The American Journal of Cardiology|April 14, 2009
Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)Patricia Tung, Stephen D Wiviott, Christopher P Cannon, et al.
Journal of the American College of Cardiology|August 21, 2012
The controversies of statin therapy: weighing the evidenceJ Wouter Jukema, Christopher P Cannon, Anton J M de Craen, et al.
Journal of the American College of Cardiology|December 5, 2009
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) SubstudyC Michael Gibson, Yuri B Pride, Claudia P Hochberg, et al.
Circulation|May 9, 2002
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarctionC Michael Gibson, Christopher P Cannon, Sabina A Murphy, et al.
The American Journal of Cardiology|June 30, 2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Amit V Khera, Arman Qamar, Sabina A Murphy, et al.
The American Journal of Cardiology|October 24, 2007
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines databaseBenjamin A Steinberg, Christopher P Cannon, Adrian F Hernandez, et al.
Pageof 86

Showing results (221-230 of 858) with videos related to

Sort By:
Pageof 86
American Heart Journal|May 26, 2009
Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF)Daniel E Forman, Christopher P Cannon, Adrian F Hernandez, et al.
Journal of the American College of Cardiology|October 16, 2010
Prior aspirin use and outcomes in acute coronary syndromesJonathan D Rich, Christopher P Cannon, Sabina A Murphy, et al.
Critical Pathways in Cardiology|August 31, 2010
Performance achievement award program for Get With The Guidelines--Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarctionKim K Birtcher, Wenqin Pan, Kenneth A Labresh, et al.
Journal of the American College of Cardiology|May 17, 2005
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trialPaul M Ridker, David A Morrow, Lynda M Rose, et al.
The American Journal of Cardiology|April 14, 2009
Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)Patricia Tung, Stephen D Wiviott, Christopher P Cannon, et al.
Journal of the American College of Cardiology|August 21, 2012
The controversies of statin therapy: weighing the evidenceJ Wouter Jukema, Christopher P Cannon, Anton J M de Craen, et al.
Journal of the American College of Cardiology|December 5, 2009
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) SubstudyC Michael Gibson, Yuri B Pride, Claudia P Hochberg, et al.
Circulation|May 9, 2002
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarctionC Michael Gibson, Christopher P Cannon, Sabina A Murphy, et al.
The American Journal of Cardiology|June 30, 2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Amit V Khera, Arman Qamar, Sabina A Murphy, et al.
The American Journal of Cardiology|October 24, 2007
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines databaseBenjamin A Steinberg, Christopher P Cannon, Adrian F Hernandez, et al.
Pageof 86